{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T05:39:11Z","timestamp":1792388351514,"version":"4.4.0"},"reference-count":49,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Child and Adolescent Psychopharmacology"],"published-print":{"date-parts":[[2026,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Post-traumatic stress disorder and trauma-related presentations in children and adolescents frequently co-occur with attention deficit hyperactivity disorder (ADHD), compounding functional impairment. Because evidence-based pediatric treatment options for trauma-related presentations remain limited and symptoms can overlap with ADHD, optimizing the choice of ADHD medications is of clinical importance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This review aimed to map and synthesize the available evidence for the utility of different ADHD medications in children and adolescents with trauma-related presentations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic scoping review was undertaken following the Joanna Briggs Institute methodology and reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews checklist. Medline, Embase, PsycINFO, and gray literature sources were searched for studies published between January 1985 and November 2025. Findings were synthesized narratively and organized by medication class.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      From 3,626 identified records, 19 were included in the final analysis (15 primary studies and 4 systematic reviews). These consisted of case reports (\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      = 8), open-label trials (\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      = 4), retrospective chart reviews (\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      = 2), and one large-scale electronic health record study. Alpha-2 agonists (guanfacine and clonidine) were associated with the most consistently reported improvements for trauma-related symptoms. Although stimulants and atomoxetine did not show consistent improvement in trauma-related symptoms across available studies, real-world data revealed that stimulant use was associated with reduced hospitalization, emergency department visits, and secondary antipsychotic or mood stabilizer prescribing in comorbid youth. No studies evaluating viloxazine were identified.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Stimulants have been shown to benefit wider long-term psychiatric outcomes, although smaller studies demonstrated a more consistent improvement in specific trauma-related symptoms with alpha-2 agonists. Rather than following a rigid medication sequence, clinicians should adopt a trauma-informed approach that prioritizes or combines treatments based on whether ADHD or trauma is the primary driver of functional impairment. However, because the current evidence is predominantly low quality and lacks controlled trials, these findings must be interpreted with caution.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10445463261470300","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:05:55Z","timestamp":1784873155000},"page":"597-606","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Utility of ADHD Medications in Children and Adolescents with Trauma-Related Presentations: A Systematic Scoping Review"],"prefix":"10.1177","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7006-1401","authenticated-orcid":false,"given":"Athif","family":"Ilyas","sequence":"first","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetika","family":"Kumar","sequence":"additional","affiliation":[{"name":"University of Oxford, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Addison","sequence":"additional","affiliation":[{"name":"Oxford Health NHS Foundation Trust, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2020.29186.bjc"},{"issue":"5","key":"e_1_3_2_4_1","first-page":"S43","article-title":"The emerging neurobiology of attention deficit hyperactivity disorder: The key role of the prefrontal association cortex","volume":"154","author":"Arnsten AF","year":"2009","unstructured":"Arnsten AF. The emerging neurobiology of attention deficit hyperactivity disorder: The key role of the prefrontal association cortex. J Pediatr 2009;154(5):I:S43.","journal-title":"J Pediatr"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/10870547261416173"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212286"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12011"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2021.113904"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2023.1173326"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.5765\/jkacap.240037"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2012.0119"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30269-4"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1089\/10445460152595649"},{"issue":"9","key":"e_1_3_2_14_1","first-page":"26F","article-title":"Antidepressants for pediatric patients","volume":"18","author":"Dwyer JB","year":"2019","unstructured":"Dwyer JB, , Bloch MH. Antidepressants for pediatric patients. Curr Psychiatr 2019;18(9):26F\u201342F.","journal-title":"Curr Psychiatr"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-29.2.107"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-021-00825-w"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199609000-00022"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199608000-00006"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","unstructured":"Ilyas A et al. (2025) Pharmacological Management of ADHD with Comorbid Anxiety or Trauma-Related Disorders in Children and Young People: A Systematic Scoping Review. OSF Registries. Available from: 10.17605\/OSF.IO\/SQYAR [Last accessed: 12April 2026].","DOI":"10.17605\/OSF.IO\/SQYAR"},{"issue":"1","key":"e_1_3_2_20_1","first-page":"e53009","article-title":"Alpha-2 agonists in children and adolescents with post-traumatic stress disorder: A systematic review","volume":"16","author":"Jagtiani A","year":"2024","unstructured":"Jagtiani A, , Gandhi R, , Banga A, et al. Alpha-2 agonists in children and adolescents with post-traumatic stress disorder: A systematic review. Cureus 2024;16(1):e53009.","journal-title":"Cureus"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2024.06.199"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-021-00453-3"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/15248380211030234"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-5-69"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30031-8"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2008.1863"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00821-2"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-025-02774-7"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107940"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/CHI.0b013e31819c23d0"},{"key":"e_1_3_2_31_1","unstructured":"National Institute for Health and Care Excellence. (2018a) Attention deficit hyperactivity disorder: Diagnosis and management. NICE guideline [NG87]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng87 [Last accessed: 12April 2026]."},{"key":"e_1_3_2_32_1","unstructured":"National Institute for Health and Care Excellence. (2018b) Post-traumatic stress disorderNICE guideline [NG116]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng116 [Last accessed: 12April 2026]."},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.3928\/00485713-20200330-01"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1521\/capn.8.8.6.27932"},{"key":"e_1_3_2_36_1","first-page":"253","volume-title":"Catecholamine Function in Post Traumatic Stress Disorder: Emerging Concepts","author":"Perry B","year":"1994","unstructured":"Perry B. (1994) Neurobiological sequelae of childhood trauma: post-traumatic stress disorders in children. In: Murburg M.(ed) Catecholamine Function in Post Traumatic Stress Disorder: Emerging Concepts. Washington, DC: American Psychiatric Association Publishing, pp. 253\u2013276."},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000050"},{"issue":"8","key":"e_1_3_2_38_1","first-page":"475","article-title":"The use of clonidine in post-traumatic stress disorder","volume":"91","author":"Porter DM","year":"1999","unstructured":"Porter DM, , Bell CC. The use of clonidine in post-traumatic stress disorder. J Natl Med Assoc 1999;91(8):475\u2013477.","journal-title":"J Natl Med Assoc"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)33004-1"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114395"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09r05446blu"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2014.0119"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-7358(98)00107-X"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2022.08.012"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.2174\/2211556011201030252"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7182.527"},{"key":"e_1_3_2_48_1","volume-title":"ICD-11: International classification of diseases (11th revision).","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. (2022) ICD-11: International classification of diseases (11th revision). Geneva: World Health Organization."},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2022.29221.bjc"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxz021"}],"container-title":["Journal of Child and Adolescent Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10445463261470300","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10445463261470300","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10445463261470300","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:41:19Z","timestamp":1792384879000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10445463261470300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,12,1]]}},"alternative-id":["10.1177\/10445463261470300"],"URL":"https:\/\/doi.org\/10.1177\/10445463261470300","relation":{},"ISSN":["1044-5463","1557-8992"],"issn-type":[{"value":"1044-5463","type":"print"},{"value":"1557-8992","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}